These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7902313)

  • 21. Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation.
    Gómez-Abecia S; Morán-Jiménez MJ; Ruiz-Casares E; Henriques-Gil N; García-Pastor I; Garrido-Astray MC; Enríquez de Salamanca R; Méndez M
    Gene; 2013 Jun; 522(1):89-95. PubMed ID: 23545314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. Mutation in brief no. 237. Online.
    McManus JF; Begley CG; Sassa S; Ratnaike S
    Hum Mutat; 1999; 13(5):412. PubMed ID: 10338097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mouse model of familial porphyria cutanea tarda.
    Phillips JD; Jackson LK; Bunting M; Franklin MR; Thomas KR; Levy JE; Andrews NC; Kushner JP
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):259-64. PubMed ID: 11134514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porphyria cutanea tarda and chronic lymphoid leukemia.
    Remenyik E; Ujj G; Kiss A; Kószó F; Horkay I
    Photodermatol Photoimmunol Photomed; 1996 Aug; 12(4):180-2. PubMed ID: 9017795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
    Bygum A; Christiansen L; Petersen NE; Hørder M; Thomsen K; Brandrup F
    Acta Derm Venereol; 2003; 83(2):115-20. PubMed ID: 12735639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is hepatoerythropoietic porphyria a homozygous form of porphyria cutanea tarda? Inheritance of uroporphyrinogen decarboxylase deficiency in a Spanish family.
    Lazaro P; de Salamanca RE; Elder GH; Villaseca ML; Chinarro S; Jaqueti G
    Br J Dermatol; 1984 May; 110(5):613-7. PubMed ID: 6722030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatoerythropoietic porphyria and familial porphyria cutanea tarda in Spanish patients: G281E mutation in the uroporphyrinogen decarboxylase gene.
    Darwich E; To-Figueras J; Badenas C; Herrero C
    Arch Dermatol; 2010 Nov; 146(11):1313-4. PubMed ID: 21079081
    [No Abstract]   [Full Text] [Related]  

  • 29. Porphyria cutanea tarda: Recent update.
    Singal AK
    Mol Genet Metab; 2019 Nov; 128(3):271-281. PubMed ID: 30683557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precipitating/aggravating factors of porphyria cutanea tarda in Spanish patients.
    Cruz-Rojo J; Fontanellas A; Morán-Jiménez MJ; Navarro-Ordóñez S; García-Bravo M; Méndez M; Muñoz-Rivero MC; de Salamanca RE
    Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):845-52. PubMed ID: 12699242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus].
    Wolff C; Stella AM; Armas R; Parraguez A; Silva H; Batlle AM
    Rev Med Chil; 1998 Mar; 126(3):245-50. PubMed ID: 9674292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porphyria cutanea tarda precipitated by ovarian stimulation during oocyte retrieval in a genetically susceptible female.
    Rasheed E; Savage S; Walsh E; Brazil N; Ralph N; Gorman PO; Crowley V
    Ann Clin Biochem; 2021 May; 58(3):251-256. PubMed ID: 33393347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda--suggestions for a handling programme.
    Thunell S; Harper P
    Scand J Clin Lab Invest; 2000 Nov; 60(7):561-79. PubMed ID: 11202050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porphyria cutanea tarda.
    Fritsch C; Lang K; von Schmiedeberg S; Bolsen K; Merk H; Lehmann P; Ruzicka T
    Skin Pharmacol Appl Skin Physiol; 1998; 11(6):321-35. PubMed ID: 10343203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between hepatitis C virus and porphyria cutanea tarda.
    To-Figueras J
    Mol Genet Metab; 2019 Nov; 128(3):282-287. PubMed ID: 31097365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda.
    Bulaj ZJ; Phillips JD; Ajioka RS; Franklin MR; Griffen LM; Guinee DJ; Edwards CQ; Kushner JP
    Blood; 2000 Mar; 95(5):1565-71. PubMed ID: 10688809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of metal ion metabolism and oxidative stress in male patients with porphyria cutanea tarda].
    Székely E; Tasnádi G; Szentmihályi K; Almási A; Bor M; Fehér J; Blázovics A
    Orv Hetil; 2007 Jun; 148(23):1095-100. PubMed ID: 17545118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage.
    Lederhandler M; Chen L; Meehan SA; Brinster NK; Neimann A
    Dermatol Online J; 2019 Dec; 25(12):. PubMed ID: 32045169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic aspects of porphyria cutanea tarda.
    Lambrecht RW; Thapar M; Bonkovsky HL
    Semin Liver Dis; 2007 Feb; 27(1):99-108. PubMed ID: 17295179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
    Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.